TYMS CLIA Kit
-
- Target Alle TYMS CLIA Kits anzeigen
- TYMS (Thymidylate Synthetase (TYMS))
-
Reaktivität
- Human
- Nachweismethode
- Chemiluminescent
- Methodentyp
- Sandwich ELISA
- Detektionsbereich
- 0.312 ng/mL - 20 ng/mL
- Untere Nachweisgrenze
- 0.312 ng/mL
- Applikation
- ELISA
- Verwendungszweck
- Human Thymidylate synthetase (TYMS) CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma, tissue homogenates and other biological fluids.
- Proben
- Plasma, Serum, Tissue Homogenate
- Analytische Methode
- Quantitative
- Sensitivität
- < 0.113 ng/mL
- Featured
- Zu unserem meistverkauften TYMS ELISA Kit
- Top Product
- Discover our top product TYMS ELISA Kit
-
-
- Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plattentyp
- Pre-coated
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Haltbarkeit
- 6 months
-
- Target Alle TYMS CLIA Kits anzeigen
- TYMS (Thymidylate Synthetase (TYMS))
- Abstract
- TYMS Produkte
- Synonyme
- FN1 CLIA Kit, ECK2823 CLIA Kit, JW2795 CLIA Kit, ts CLIA Kit, Ts CLIA Kit, HST422 CLIA Kit, TMS CLIA Kit, TS CLIA Kit, thymidylate synthetase CLIA Kit, contains intron in T4 phage CLIA Kit, ThyE CLIA Kit, thymidylate synthase CLIA Kit, thymidylate synthetase L homeolog CLIA Kit, TYMS CLIA Kit, thyA CLIA Kit, td CLIA Kit, thyE CLIA Kit, DDA3937_RS04960 CLIA Kit, tyms.L CLIA Kit, XBJ1_RS15770 CLIA Kit, EAMY_RS20680 CLIA Kit, Tyms CLIA Kit
- Substanzklasse
- Viral Protein
- Pathways
- Mitotic G1-G1/S Phases
-